Skip to content

News

Advocate’s Corner: March 2024

Advocate’s Corner: March 2024

It was a busy and exciting month for OCRA’s policy team and advocates from all across the country. OCRA’s 2024 Spring Advocacy Day took place on March 20, during which 140 advocates met with their Members of Congress and urged them to support increased funding for education and research programs focused on ovarian and related … Continued

OCRA’s 2024 Grantees: Collaborative Studies & AI

OCRA’s 2024 Grantees: Collaborative Studies & AI

OCRA’s four Collaborative Research Development Grants, including a partnership grant through Microsoft AI for Health, are multi-investigator studies set to tackle the most pressing issues in research, treatment and care. “In an all-around stellar crop of new OCRA-funded research for 2024, our collaborative studies hold particular promise,” says Audra Moran, OCRA’s President & CEO.  “By … Continued

The Overview: February 2024

The Overview: February 2024

OCRA Harnessing Artificial Intelligence to Develop Blood Test to Detect Ovarian Cancer In a news segment for NBC 4 New York, Dr. Daniel Heller, an OCRA grantee, discussed the exciting OCRA-funded study being undertaken in partnership with Microsoft AI for Health.   “We’re really excited about the power of AI because there has been so much success in … Continued

Transforming Music Into a Means to Help | OCRA Heroes

Transforming Music Into a Means to Help | OCRA Heroes

Get inspired by these OCRA Heroes who have tapped into live music’s incredible power to bring people together and transformed it into support for Ovarian Cancer Research Alliance (OCRA). They have organized multiple benefit concerts, which provide a meaningful avenue to honor the memory of their loved ones who passed away from ovarian cancer. Event … Continued

Advocate’s Corner: February 2024

Advocate’s Corner: February 2024

OCRA’s Advocates are off to a running start this year with help from our largest Advocate Leader cohort in program history, at 125 participants representing 39 states and 111 congressional districts. Together with the OCRA policy team, Advocate Leaders are working to advance crucial legislative goals, including expanding federal funding of ovarian and other gynecologic cancer … Continued

OCRA Invests Record $9.2 Million in Research Initiatives for 2024

OCRA Invests Record $9.2 Million in Research Initiatives for 2024

Research breakthroughs are around the corner. In 2023, OCRA announced $9.2 million in research initiatives for 2024 — the largest in our history — including awarding 20 grants to scientists at 15 prestigious institutions. Recommended for funding by OCRA’s Scientific Advisory Committee from a competitive evaluation process, these exceptional researchers and their forward-thinking studies will tackle … Continued

(Video) OCRA Researchers Using AI to Potentially Detect Ovarian Cancer

(Video) OCRA Researchers Using AI to Potentially Detect Ovarian Cancer

An OCRA research team is using Artificial Intelligence (AI) to develop a blood test to potentially detect ovarian cancer, as part of an OCRA-funded study in partnership with Microsoft AI for Good Lab. OCRA grantee Daniel Heller, PhD, lead researcher at The Daniel Heller Lab at Memorial Sloan Kettering Cancer Center discusses this cutting-edge technology … Continued

Celebrating Love, Resilience and Creativity in the Face of Cancer

Celebrating Love, Resilience and Creativity in the Face of Cancer

Ovarian Cancer Research Alliance brought together nearly 60 individuals impacted by a gynecologic cancer to participate in special programming earlier this season focused on the documentary “American Symphony,” which explores how the immense love and creative talents of an award-winning artistic couple have helped them cope with cancer’s impact on their lives and relationship. “American … Continued

Ask the Experts | What Holds Promise in Ovarian Cancer Research?

Ask the Experts | What Holds Promise in Ovarian Cancer Research?

What do you feel holds great promise in the field of ovarian cancer research and treatment? “We have made great progress in understanding the molecular biology of ovarian cancer. Continuing efforts to understand it – and the tumor microenvironment – will allow us the opportunity to identify new and more effective ways to prevent and treat … Continued

Livnat Jerby, PhD | Meet a Scientist

Livnat Jerby, PhD | Meet a Scientist

Livnat Jerby, PhD, is Assistant Professor in the Department of Genetics at Stanford University and a 2022 recipient of OCRA’s Early Career Investigator Grant. Through her OCRA-funded project, she is utilizing cutting-edge technologies to gain new insights into the specific mechanisms that allow ovarian cancer to escape the immune system. She aims to pave the way to … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.